AnaptysBio, Inc. (ANAB) vs Omeros Corporation (OMER)
- AnaptysBio, Inc. ANAB 46.61 −4.31%
- Omeros Corporation OMER 16.20 −13.78%
AnaptysBio, Inc. and Omeros Corporation are both Biotechnology companies. AnaptysBio, Inc. and Omeros Corporation are of similar size ($1.5B and $1.4B). AnaptysBio, Inc. has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 9.5×. AnaptysBio, Inc. grew revenue faster over the last twelve months: 107.7% against 36.3%. Omeros Corporation has the higher net margin (128.4% vs −11.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, AnaptysBio, Inc. leads on 9 and Omeros Corporation on 7.
Valuation
Profitability
| Metric | ANAB | OMER | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 37.57% | 65.16% |
| Operating margin | 17.56% | (74.88%) | 0.00% |
| Net margin | (11.53%) | 128.36% | 0.00% |
| Free cash flow margin | 1.90% | (70.69%) | 0.00% |
| Return on equity | (114.55%) | (89.15%) | (56.36%) |
| Return on assets | (7.13%) | 51.22% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack